Search

Your search keyword '"Donas, J."' showing total 116 results

Search Constraints

Start Over You searched for: Author "Donas, J." Remove constraint Author: "Donas, J." Database OAIster Remove constraint Database: OAIster
116 results on '"Donas, J."'

Search Results

1. UV properties of early-type galaxies in the Virgo Cluster

2. Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety

3. Rucaparib maintenance treatment for recurrent ovarian carcinoma: The effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3

4. The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma

5. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

6. Prognostic gene expression signature for high-grade serous ovarian cancer.

7. Prognostic gene expression signature for high-grade serous ovarian cancer

8. Prognostic gene expression signature for high-grade serous ovarian cancer.

9. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

10. The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma

11. Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients with Recurrent Ovarian Carcinoma

12. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

13. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

14. Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity

15. Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients

16. Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity

17. Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity

19. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): A randomised, double-blind, placebo-controlled, phase 3 trial

20. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

21. Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

22. Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

23. IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

25. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

26. GALEX-SDSS Catalogs for Statistical Studies

27. GALEX-SDSS Catalogs for Statistical Studies

28. Chemical and Photometric Evolution of Extended Ultraviolet Disks: Optical Spectroscopy of M83 (NGC5236) and NGC4625

29. Deep GALEX Imaging of the HST/COSMOS Field: A First Look at the Morphology of z~0.7 Star-forming Galaxies

30. UV to IR SEDs of UV selected galaxies in the ELAIS fields: evolution of dust attenuation and star formation activity from z=0.7 to z=0.2

31. UV to IR SEDs of UV selected galaxies in the ELAIS fields: evolution of dust attenuation and star formation activity from z=0.7 to z=0.2

32. UV to IR SEDs of UV selected galaxies in the ELAIS fields: evolution of dust attenuation and star formation activity from z=0.7 to z=0.2

33. Chemical and Photometric Evolution of Extended Ultraviolet Disks: Optical Spectroscopy of M83 (NGC5236) and NGC4625

34. Deep GALEX Imaging of the HST/COSMOS Field: A First Look at the Morphology of z~0.7 Star-forming Galaxies

35. The Local Universe as Seen in Far-Infrared and in Far-Ultraviolet: A Global Point of View on the Local Recent Star Formation

36. Dissecting Galaxy Colors with GALEX, SDSS, and Spitzer

37. The GALEX Ultraviolet Atlas of Nearby Galaxies

38. Star formation in the nearby universe: the ultraviolet and infrared points of view

39. The effect of environment on the UV colour-magnitude relation of early-type galaxies

40. UV-optical colours as probes of early-type galaxy evolution

41. The Local Universe as Seen in Far-Infrared and in Far-Ultraviolet: A Global Point of View on the Local Recent Star Formation

42. The GALEX Ultraviolet Atlas of Nearby Galaxies

43. Dissecting Galaxy Colors with GALEX, SDSS, and Spitzer

44. Star formation in the nearby universe: the ultraviolet and infrared points of view

45. UV-optical colours as probes of early-type galaxy evolution

46. The effect of environment on the UV colour-magnitude relation of early-type galaxies

47. GALEX UV observations of the interacting galaxy NGC 4438 in the Virgo cluster

48. UV properties of early-type galaxies in the Virgo cluster

49. The GALEX UV luminosity function of the cluster of galaxies Abell 1367

50. The GALEX UV luminosity function of the cluster of galaxies Abell 1367

Catalog

Books, media, physical & digital resources